[CITATION][C] The VERTIS CV trial: cardiovascular outcomes following ertugliflozin treatment in patients with type 2 diabetes mellitus and atherosclerotic cardiovascular …
RE Pratley, S Dagogo-Jack, CP Cannon, DK McGuire… - … Diabetes Association Virtual …, 2020
[CITATION][C] The VERTIS CV trial. Cardiovascular outcomes following ertugliflozin treatment in patients with type 2 diabetes mellitus and atherosclerotic cardiovascular …
CP Cannon, DK McGuire, R Pratley